We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,383

Are IP Addresses PII? Why Businesses Should Be Cautious About IP Addresses
  • Fenwick & West LLP
  • European Union, USA
  • October 24 2016

We often hear the following phrase from clients: "We are not collecting PII, we only collect IP addresses." Companies may be surprised to hear that


Royalties for revoked patents do not necessarily breach EU competition rules
  • Penningtons Manches LLP
  • European Union, Germany, USA
  • October 25 2016

It is hard to imagine that when Genentech signed a licence agreement in 1992 with Sanofi's predecessor, it could have foreseen the litigation storm


Food, Dietary Supplement & Cosmetics Regulatory Update Vol. III, Issue 13
  • Jones Day
  • European Union, OECD, USA
  • October 6 2016

On September 28, 2016,FDA announced it has started a public process to redefine the "healthy" nutrient content claim for food labeling. On December 1


EMA and FDA set up new working group on rare diseases
  • Hogan Lovells
  • European Union, USA
  • October 6 2016

On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA


Biological deposits and priority
  • Marks & Clerk
  • European Union, USA
  • April 23 2013

As a result of decision T010709, issued by an EPO Technical Board of Appeal on 12 July 2012, practitioners outside Europe and especially in the US


10 steps global life sciences companies should take in 2014 to address EU developments
  • Sidley Austin LLP
  • European Union, USA
  • February 24 2014

2014 will be a year of unprecedented changes for the life sciences industry in Europe, including changes to fundamental aspects of several EU laws


Global corporate insurance & regulatory bulletin
  • Mayer Brown JSM
  • China, European Union, United Kingdom, USA
  • December 5 2013

The China Insurance Regulatory Commission (“CIRC”) announced new rules (Implementing Rules of Provisional Measures on Outbound Investments with


E-Commerce Law Week, Issue 922
  • Steptoe & Johnson LLP
  • European Union, USA
  • October 29 2016

On October 18, the Department of Health and Human Services (HHS) announced a


Transatlantic developments in relation to the antitrust analysis of reverse payment settlements: Lundbeck and Actavis
  • NautaDutilh
  • European Union, USA
  • June 21 2013

Lundbeck held various patents relating to citalopram, both in respect of the substance itself and in respect of various production processes. When the


Dispelling the Myriad gene patent harmonization myth
  • Foley & Lardner LLP
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the